initial public offerings (IPOs) trading on American exchanges

Friday, September 27, 2024

BioAge Labs (BIOA) began trading on the Nasdaq on Thr 26 Sept 24

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. 
  • Founded by Kristen Fortney and Eric Morgen on April 1, 2015 
  • Headquartered in Richmond, CA.
  • Website: bioagelabs.com
  • Employees: 59

No comments:

Post a Comment